1. Home
  2. EXTR vs GPCR Comparison

EXTR vs GPCR Comparison

Compare EXTR & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Extreme Networks Inc.

EXTR

Extreme Networks Inc.

HOLD

Current Price

$22.04

Market Cap

3.9B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$46.89

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXTR
GPCR
Founded
1996
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.8B
IPO Year
1999
2023

Fundamental Metrics

Financial Performance
Metric
EXTR
GPCR
Price
$22.04
$46.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
12
Target Price
$21.20
$103.17
AVG Volume (30 Days)
1.7M
566.8K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
616.67
N/A
EPS
0.31
N/A
Revenue
$1,283,593,000.00
N/A
Revenue This Year
$13.33
N/A
Revenue Next Year
$7.97
N/A
P/E Ratio
$71.00
N/A
Revenue Growth
12.59
N/A
52 Week Low
$13.48
$19.50
52 Week High
$33.73
$94.90

Technical Indicators

Market Signals
Indicator
EXTR
GPCR
Relative Strength Index (RSI) 33.53 40.86
Support Level $16.48 $46.40
Resistance Level $25.20 $56.63
Average True Range (ATR) 0.71 2.26
MACD 0.09 -0.59
Stochastic Oscillator 7.85 18.76

Price Performance

Historical Comparison
EXTR
GPCR

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: